What If an Algorithm Could Predict Your Unborn Child’s Intelligence?
Stephen Hsu’s startup Genomic Predictions analyzes genetic data to predict the chance of diseases like diabetes and cancer — and forecast IQ
For years, hopeful parents pursuing in vitro fertilization (IVF) treatment have had the option of screening embryos for severe heritable diseases like cystic fibrosis, hemophilia, and Tay-Sachs disease. These rare and often deadly conditions, known as monogenic disorders, can be easily identified through genetic screening because they arise due to a mutation on a single gene. For doctors, diagnosis is a simple positive or negative.
But the diseases that are most likely to shadow the average person’s life — cancer, heart disease, diabetes — are polygenic, meaning that they result from interactions between thousands of genetic signals. In the past, this has made these diseases — which kill millions of Americans each year — all but impossible to screen for with genetic tests.
But Genomic Prediction, a New Jersey-based company that analyzes genetic data using machine learning, is hoping to change that. Taking advantage of the new troves of genetic sequences that have accumulated over the past decade, the company is offering what is known as polygenic…
